Range
- - -
Vol / Avg.
-/1.5M
Div / Yield
-
52 Wk
59.33 - 104.86
Mkt Cap
23.1B
Payout Ratio
-
Open
-
P/E
77.15
EPS
0.86
Shares
224.8M
Outstanding
224.8M
Total Float
217.8M
load more
Sector: Health Care.Industry: Biotechnology
Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS0.0400.030 -0.0100
REV330.730M342.406M11.676M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HZNPHorizon Therapeutics-0.64%23.1B

Horizon Therapeutics Frequently Asked Questions

Q

How do I buy Horizon Therapeutics (HZNP) stock?

A

You can purchase shares of Horizon Therapeutics (NASDAQ: HZNP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Horizon Therapeutics's (HZNP) competitors?

Q

What is the target price for Horizon Therapeutics (HZNP) stock?

A

The latest price target for Horizon Therapeutics (NASDAQ: HZNP) was reported by Morgan Stanley on March 22, 2021. The analyst firm set a price target for 103.00 expecting HZNP to rise to within 12 months (a possible 0.38% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Horizon Therapeutics (HZNP)?

A

The stock price for Horizon Therapeutics (NASDAQ: HZNP) is $102.61 last updated Thu Jul 29 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Horizon Therapeutics (HZNP) pay a dividend?

A

There are no upcoming dividends for Horizon Therapeutics.

Q

When is Horizon Therapeutics (NASDAQ:HZNP) reporting earnings?

A
Horizon Therapeutics’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Horizon Therapeutics (HZNP) going to split?

A

There is no upcoming split for Horizon Therapeutics.

Q

What sector and industry does Horizon Therapeutics (HZNP) operate in?

A

Horizon Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.